| Date | Author | Type | Reco Price | Target Price | Potential | Source | PDF Link |
|---|---|---|---|---|---|---|---|
| 03 Nov 2025 | Anand Rathi | Buy | ₹575.1 | ₹690 | 14.1% | moneycontrol | View |
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| Fabino Enterprises Ltd | NA | NA | NA | NA | 5.09 | 84.8 |
| Triochem Products Ltd | 2.21 | -1.32 | NA | -5.38 | 0 | |
| Indraprastha Medical Corporation Limited | 3787.6 | 410.0 | 3716.1 | 4.47 | 4,096 | 24.4 |
| RPG Life Sciences Limited | 1834.4 | 221.3 | 1800.3 | 0 | 3813 | 36.8 |
| Orchid Pharma Limited | 2128.76 | -126.14 | 2072.67 | -2.49 | 3659 | 42.9 |
Indraprastha Medical Corporation Lt, with Security Code 532150, is a leading player in the Hospital industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Sales | 314.7 | 347.9 | 349.8 | 324.9 | 333.8 | 365.1 | 381.0 | 371.6 |
| Expenses | 266.3 | 280.7 | 286.2 | 272.7 | 272.4 | 291.9 | 309.7 | 309.7 |
| Operating Profit | 48.4 | 67.1 | 63.6 | 52.2 | 61.4 | 73.2 | 71.3 | 62.0 |
| OPM % | 15.39% | 19.3% | 18.19% | 16.06% | 18.38% | 20.04% | 18.72% | 16.67% |
| Other Income | 4.9 | 5.1 | 6.1 | 5.1 | 6.4 | 6.9 | 7.4 | 7.2 |
| Interest | 1.6 | 1.6 | 1.6 | 1.6 | 1.5 | 1.6 | 1.5 | 1.5 |
| Depreciation | 10.2 | 11.0 | 11.2 | 11.2 | 10.9 | 10.2 | 10.9 | 11.3 |
| Profit before tax | 41.6 | 59.6 | 56.9 | 44.5 | 55.3 | 68.3 | 66.3 | 56.4 |
| Tax % | -25% | 24.9% | 25.5% | 26.3% | -25.7% | 24.7% | 25.4% | 27.3% |
| Net Profit | 31.2 | 44.8 | 42.4 | 32.8 | 41.0 | 51.5 | 49.5 | 41.0 |
| EPS in Rs | 3.4 | 4.88 | 4.63 | 3.58 | 0 | 5.61 | 5.4 | 4.47 |
No Consolidated data available.
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 10% |
| 3 Years: | 15% |
| TTM: | 9% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 29% |
| 3 Years: | 37% |
| TTM: | 29% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 22% |
| 5 Years: | 62% |
| 3 Years: | 92% |
| 1 Year: | 68% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| 1 Year: | 0% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| News Date ▲▼ | Headline ▲▼ | Issuer Entity ▲▼ | Issuer Type ▲▼ | Order Size ▲▼ | Time Period ▲▼ | |
|---|---|---|---|---|---|---|
| Loading company updates… | ||||||
We couldn’t find any filings or updates in the Company News collection for this BSE code.
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|